🇺🇸 FDA
Patent

US 9511067

Substituted spiro[piperidine-4,1'-pyrrolo[1,2-a]pyrazine]s as modulators of ion channels

granted A61KA61K31/499A61K31/506

Quick answer

US patent 9511067 (Substituted spiro[piperidine-4,1'-pyrrolo[1,2-a]pyrazine]s as modulators of ion channels) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Dec 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/499, A61K31/506, A61P, A61P1/00